|
Gaydukova I.Z., Petukhova A.A., Bombina M.V., Bandurko E.P., Inamova O.V., Mazurov V.I.
Aseptic necrosis in the practice of a therapist – treatment efficacy based on one-year period of observation
|
№1 / 2025
|
|
Savlevich E.L., Markus P.V., Angotoeva I.B., Kirichenko I.M., Bessonov K.K.
Causes of pain syndrome in case of oropharynx inflammatory diseases
|
№6 / 2024
|
|
Golendyaeva P.I., Livzan M.A., Gaus O.V., Korennova O.Yu., Mozgovoy S.I.
Gastropathy associated with antiplatelet and anticoagulant therapy: prevalence and risk factors
|
№8 / 2023
|
|
Dronova Yu.M., Mubarakshina O.A., Chernov S.Yu.
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use
|
№5 / 2023
|
|
Bolieva L.Z., Adasheva T.V., Daurova M.D.
Coxibs cardiovascular safety
|
№4 / 2023
|
|
Rebrov A.P., Tyapkina M.A., Ordyakova A.A., Yupatov V.D., Kosheleva N.A., Basov I.V.
Patients with cardiovascular diseases and NSAIDs intake: Is there a real problem today?
|
№4 / 2023
|
|
|
№3 (приложение) / 2023
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 2: management of patients with cardiovascular, gastrointestinal, renal, liver diseases, pregnancy, also having anticoagulant therapy and patients in perioperative period
|
№2 / 2023
|
|
Kudina E.V. Samkova I.A.
Anti-inflammatory therapy of joint syndrome in an outpatient practitioner
|
№1 / 2023
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy
|
№1 / 2023
|
|
Trofimov E.A., Mazurov V.I., Bashkinov R.A., Trofimova A.S., Gaydukova I.Z.
Comparative analysis of efficacy and safety of different medicines containing celecoxib in patients with knee osteoarthritis
|
№1 / 2023
|
|
Viktorova I.A., Ivanova D.S., Konshu N.V.
Prospective two-year observation of patients with the syndrome of joint hypermobility
|
№7 / 2019
|
Русский
